Yasar Sattar, Mohammad Hamza, Farah Yasmin, Sidra Jabeen, Neel Patel, Syed Ishaq, Bandar Alyami, Hassan Ul Hussain, Syeda Tayyaba Rehan, Syed Hasan Shuja, Zayeema Khan, Yasemin Bahar, Islam Y Elgendy, Karthik Gonuguntla, Harshith Thyagaturu, Akram Kawsara, Kevin Felpel, Ramesh Daggubati, M Chadi Alraies
{"title":"重度主动脉瓣狭窄患者急诊与择期经导管主动脉瓣置换术的心血管预后:回归匹配荟萃分析。","authors":"Yasar Sattar, Mohammad Hamza, Farah Yasmin, Sidra Jabeen, Neel Patel, Syed Ishaq, Bandar Alyami, Hassan Ul Hussain, Syeda Tayyaba Rehan, Syed Hasan Shuja, Zayeema Khan, Yasemin Bahar, Islam Y Elgendy, Karthik Gonuguntla, Harshith Thyagaturu, Akram Kawsara, Kevin Felpel, Ramesh Daggubati, M Chadi Alraies","doi":"10.62347/PORE5631","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve replacement (TAVR) has been highly increased as the recommended option for patients with a high surgical risk. This study aims to commit a systematic review and meta-analysis to assess the outcomes in severe aortic stenosis patients following emergency transcatheter aortic valve replacement (emergent TAVR) compared to elective TAVR or eBAV followed by elective TAVR.</p><p><strong>Methods: </strong>We conducted a systematic literature search of PubMed, Embase, Cochrane CENTRAL, CINAHL, Science Direct, and Google Scholar. We included nine studies in the latest analysis that reported the desired outcomes. Outcomes were classified into primary outcomes: 30-day all-cause mortality and 30-day readmission rate, and secondary outcomes, which were further divided into (a) peri-procedural outcomes, (b) vascular outcomes, and (c) renal outcomes. Statistical analysis was performed using Stata v.17 (College State, TX) software.</p><p><strong>Results: </strong>A total of 44,731 patients with severe aortic stenosis were included (emergent TAVR n = 4502; control n = 40045). 30-day mortality was significantly higher in the emergent TAVR group (OR: 2.62; 95% CI = 1.76-3.92; P < 0.01). Regarding post-procedural outcomes, the length of stay was significantly higher in the emergent TAVR group (Hedges's g: +4.73 days; 95% CI = +3.35 to +6.11; P < 0.01). With respect to vascular outcomes, they were similar in both groups. Regarding renal outcomes, both acute kidney injury (OR: 2.52; 95% CI = 1.59-4.00; P < 0.01) and use of renal replacement therapy (OR: 2.33; 95% CI = 1.87-2.91; P < 0.01) were significantly higher in emergent TAVR group as compared to the control group.</p><p><strong>Conclusion: </strong>Our study demonstrated that despite increased 30-day mortality and worse renal outcomes, the post-procedural outcomes were similar in emergent and elective TAVR groups. The increased mortality and worse renal outcomes are likely due to hemodynamic instability in the emergent group. The similarity of post-procedural outcomes is evidence of the safety of TAVR even in emergent settings.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11101960/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cardiovascular outcomes of emergent vs elective transcatheter aortic valve replacement in severe aortic stenosis: regression matched meta-analysis.\",\"authors\":\"Yasar Sattar, Mohammad Hamza, Farah Yasmin, Sidra Jabeen, Neel Patel, Syed Ishaq, Bandar Alyami, Hassan Ul Hussain, Syeda Tayyaba Rehan, Syed Hasan Shuja, Zayeema Khan, Yasemin Bahar, Islam Y Elgendy, Karthik Gonuguntla, Harshith Thyagaturu, Akram Kawsara, Kevin Felpel, Ramesh Daggubati, M Chadi Alraies\",\"doi\":\"10.62347/PORE5631\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Transcatheter aortic valve replacement (TAVR) has been highly increased as the recommended option for patients with a high surgical risk. This study aims to commit a systematic review and meta-analysis to assess the outcomes in severe aortic stenosis patients following emergency transcatheter aortic valve replacement (emergent TAVR) compared to elective TAVR or eBAV followed by elective TAVR.</p><p><strong>Methods: </strong>We conducted a systematic literature search of PubMed, Embase, Cochrane CENTRAL, CINAHL, Science Direct, and Google Scholar. We included nine studies in the latest analysis that reported the desired outcomes. Outcomes were classified into primary outcomes: 30-day all-cause mortality and 30-day readmission rate, and secondary outcomes, which were further divided into (a) peri-procedural outcomes, (b) vascular outcomes, and (c) renal outcomes. Statistical analysis was performed using Stata v.17 (College State, TX) software.</p><p><strong>Results: </strong>A total of 44,731 patients with severe aortic stenosis were included (emergent TAVR n = 4502; control n = 40045). 30-day mortality was significantly higher in the emergent TAVR group (OR: 2.62; 95% CI = 1.76-3.92; P < 0.01). Regarding post-procedural outcomes, the length of stay was significantly higher in the emergent TAVR group (Hedges's g: +4.73 days; 95% CI = +3.35 to +6.11; P < 0.01). With respect to vascular outcomes, they were similar in both groups. Regarding renal outcomes, both acute kidney injury (OR: 2.52; 95% CI = 1.59-4.00; P < 0.01) and use of renal replacement therapy (OR: 2.33; 95% CI = 1.87-2.91; P < 0.01) were significantly higher in emergent TAVR group as compared to the control group.</p><p><strong>Conclusion: </strong>Our study demonstrated that despite increased 30-day mortality and worse renal outcomes, the post-procedural outcomes were similar in emergent and elective TAVR groups. The increased mortality and worse renal outcomes are likely due to hemodynamic instability in the emergent group. The similarity of post-procedural outcomes is evidence of the safety of TAVR even in emergent settings.</p>\",\"PeriodicalId\":7427,\"journal\":{\"name\":\"American journal of cardiovascular disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11101960/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of cardiovascular disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.62347/PORE5631\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of cardiovascular disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62347/PORE5631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:经导管主动脉瓣置换术(TAVR)作为手术风险高的患者的推荐选择,已被广泛采用。本研究旨在通过系统综述和荟萃分析,评估重度主动脉瓣狭窄患者紧急经导管主动脉瓣置换术(紧急 TAVR)与择期 TAVR 或 eBAV 后择期 TAVR 的治疗效果:我们对 PubMed、Embase、Cochrane CENTRAL、CINAHL、Science Direct 和 Google Scholar 进行了系统的文献检索。我们在最新分析中纳入了 9 项报告预期结果的研究。结果分为主要结果:30 天全因死亡率和 30 天再入院率;次要结果又分为 (a) 围手术期结果、(b) 血管结果和 (c) 肾脏结果。统计分析使用Stata v.17 (College State, TX)软件进行:结果:共纳入 44731 名重度主动脉瓣狭窄患者(急诊 TAVR n = 4502;对照组 n = 40045)。急诊 TAVR 组的 30 天死亡率明显更高(OR:2.62;95% CI = 1.76-3.92;P <0.01)。关于术后结果,急诊 TAVR 组的住院时间明显更长(Hedges's g:+4.73 天;95% CI = +3.35 至 +6.11;P < 0.01)。在血管方面,两组的结果相似。在肾脏结果方面,与对照组相比,急诊TAVR组的急性肾损伤(OR:2.52;95% CI = 1.59-4.00;P < 0.01)和肾脏替代疗法的使用(OR:2.33;95% CI = 1.87-2.91;P < 0.01)均显著增加:我们的研究表明,尽管急诊组和择期 TAVR 组的 30 天死亡率和肾脏预后较差,但术后预后相似。急诊组死亡率增加和肾脏预后恶化可能是由于血流动力学不稳定造成的。术后结果的相似性证明了 TAVR 的安全性,即使在急诊情况下也是如此。
Cardiovascular outcomes of emergent vs elective transcatheter aortic valve replacement in severe aortic stenosis: regression matched meta-analysis.
Background: Transcatheter aortic valve replacement (TAVR) has been highly increased as the recommended option for patients with a high surgical risk. This study aims to commit a systematic review and meta-analysis to assess the outcomes in severe aortic stenosis patients following emergency transcatheter aortic valve replacement (emergent TAVR) compared to elective TAVR or eBAV followed by elective TAVR.
Methods: We conducted a systematic literature search of PubMed, Embase, Cochrane CENTRAL, CINAHL, Science Direct, and Google Scholar. We included nine studies in the latest analysis that reported the desired outcomes. Outcomes were classified into primary outcomes: 30-day all-cause mortality and 30-day readmission rate, and secondary outcomes, which were further divided into (a) peri-procedural outcomes, (b) vascular outcomes, and (c) renal outcomes. Statistical analysis was performed using Stata v.17 (College State, TX) software.
Results: A total of 44,731 patients with severe aortic stenosis were included (emergent TAVR n = 4502; control n = 40045). 30-day mortality was significantly higher in the emergent TAVR group (OR: 2.62; 95% CI = 1.76-3.92; P < 0.01). Regarding post-procedural outcomes, the length of stay was significantly higher in the emergent TAVR group (Hedges's g: +4.73 days; 95% CI = +3.35 to +6.11; P < 0.01). With respect to vascular outcomes, they were similar in both groups. Regarding renal outcomes, both acute kidney injury (OR: 2.52; 95% CI = 1.59-4.00; P < 0.01) and use of renal replacement therapy (OR: 2.33; 95% CI = 1.87-2.91; P < 0.01) were significantly higher in emergent TAVR group as compared to the control group.
Conclusion: Our study demonstrated that despite increased 30-day mortality and worse renal outcomes, the post-procedural outcomes were similar in emergent and elective TAVR groups. The increased mortality and worse renal outcomes are likely due to hemodynamic instability in the emergent group. The similarity of post-procedural outcomes is evidence of the safety of TAVR even in emergent settings.